Long-term reductions in acute headache medication use after eptinezumab treatment in patients with migraine and prior preventive treatment failures: Post hoc analysis of the DELIVER randomized trial.

Autor: Gryglas-Dworak A; MIGRE Polish Migraine Center, Wrocław, Poland., Schim J; Neurology Center of Southern California, Carlsbad, California, USA., Ettrup A; H. Lundbeck A/S, Copenhagen, Denmark., Boserup LP; H. Lundbeck A/S, Copenhagen, Denmark., Josiassen MK; H. Lundbeck A/S, Copenhagen, Denmark., Ranc K; H. Lundbeck A/S, Copenhagen, Denmark., Sperling B; H. Lundbeck A/S, Copenhagen, Denmark., Ashina M; Department of Neurology, Danish Headache Center, Copenhagen University Hospital-Rigshospitalet, Copenhagen, Denmark.; Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

Publikováno v: Headache [Headache] 2024 Nov 05. Date of Electronic Publication: 2024 Nov 05.

CO157 Reductions in Acute Headache Medication Use after Eptinezumab Treatment in Patients with Chronic Migraines and Medication-Overuse Headache: Exploratory Analysis of PROMISE-2

Autor: Cowan, RP, Marmura, MJ, Diener, Hans Christoph, Starling, AJ, Schim, J, Hirman, J, Brevig, T, Cady, R

Publikováno v: Value in Health. 25:S333-S334

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9334e17b20d091bf33cf2ea894bbb244
https://doi.org/10.1016/j.jval.2022.04.250

Quantity changes in acute headache medication use among patients with chronic migraine treated with eptinezumab: subanalysis of the PROMISE-2 study.

Autor: Cowan RP; Stanford Health Care, Palo Alto, CA, USA., Marmura MJ; Jefferson Headache Center, Philadelphia, PA, USA., Diener HC; Medical Faculty of the University Duisburg-Essen, Institute for Medical Informatics, Biometry and Epidemiology, Essen, Germany., Starling AJ; Mayo Clinic Arizona, Scottsdale, AZ, USA., Schim J; The Neurology Center of Southern California, Carlsbad, CA, USA., Hirman J; Pacific Northwest Statistical Consulting, Inc., Woodinville, WA, USA., Brevig T; H. Lundbeck A/S, Valby, Denmark., Cady R; Lundbeck LLC, Deerfield, IL, USA. rcady@rkconsults.com.; RK Consults, Ozark, MO, USA. rcady@rkconsults.com.; Missouri State University, Springfield, MO, USA. rcady@rkconsults.com.

Publikováno v: The journal of headache and pain [J Headache Pain] 2022 Sep 06; Vol. 23 (1), pp. 115. Date of Electronic Publication: 2022 Sep 06.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Real-World Treatment Profiles, Clinical Outcomes, and Healthcare Resource Utilization of Patients with Migraine Prescribed Erenumab: A Multicenter Chart-Review Study of US Headache Centers.

Autor: Faust E; Analysis Group, Inc., 151 W 42nd St, 23rd Floor, New York, NY, 10036, USA. Lizzie.murdoch@analysisgroup.com., Pivneva I; Analysis Group, Inc., Montreal, QC, Canada., Yang K; Analysis Group, Inc., 151 W 42nd St, 23rd Floor, New York, NY, 10036, USA., Betts KA; Analysis Group, Inc., Los Angeles, CA, USA., Ahmed Z; Center for Neurological Restoration, Cleveland Clinic, Cleveland, OH, USA., Joshi S; DENT Neurologic Institute, Amherst, NY, USA., Hogan R; DENT Neurologic Institute, Amherst, NY, USA., Blumenfeld A; The Headache Center of Southern California, Carlsbad, CA, USA., Schim J; The Headache Center of Southern California, Carlsbad, CA, USA., Feoktistov A; Diamond Headache Clinic, Chicago, IL, USA., Carnes K; Raleigh Neurology Associates, Raleigh, NC, USA., Bensink M; Amgen Inc., Thousand Oaks, CA, USA., Wu EQ; Analysis Group, Inc., Boston, MA, USA., Chou DE; Amgen Inc., Thousand Oaks, CA, USA., Chandler D; Amgen Inc., Thousand Oaks, CA, USA.

Publikováno v: Neurology and therapy [Neurol Ther] 2021 Jun; Vol. 10 (1), pp. 293-306. Date of Electronic Publication: 2021 Apr 15.